Skip to main content

Year: 2025

Crazy Woman Creek Bancorp Reports Earnings for Fiscal Year 2025; Declares Annual Cash Dividend of $0.32 Per Share

BUFFALO, Wyo., Dec. 24, 2025 (GLOBE NEWSWIRE) — We continue to build our franchise as Crazy Woman Creek Bancorp (OTCPink: CRZY) and Buffalo Federal Bank, known as The Banks of Buffalo, Sheridan, Gillette and BFSB Mortgage of Evanston. Headquartered in Buffalo, Wyoming, our bank remains a vital business and community partner since founding in 1936. We take great pride in meeting our customers’ banking needs with a passion for local decision-making and personal involvement in our communities. Our vision remains to be the premier community bank serving the needs of individuals, families and businesses throughout North-Central Wyoming.  Given our continuing commitment to shareholders, we have declared an annual cash dividend of $0.34 per share, increased over the prior year’s dividend of $0.32, to be paid in January 2026. Crazy Woman...

Continue reading

ECD Automotive Design Reports Early Traction From Third-Party Build Agreement

Initial Orders Validate Demand and Support Factory Utilization Strategy KISSIMMEE, Fla., Dec. 24, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (“ECD” or the “Company”) (NASDAQ: ECDA), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs, and Toyota FJs, today provided an update on the third-party build agreement announced earlier this month, highlighting early commercial traction and progress to increase factory utilization and improve fixed-cost absorption. Since announcing the agreement with a regional 4×4 restoration client, ECD has received its first six orders. The Company expects to execute these builds at its Kissimmee, Florida facility across the first and second quarters of 2026. ECD has allocated...

Continue reading

Jeffs’ Brands and Scanary: The Radar Revolution That Could Transform the Homeland-Security Market

Tel Aviv, Israel, Dec. 24, 2025 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd. (Nasdaq: JFBR) (“Jeffs’ Brands”),  a data-driven e-commerce company strategically pivoting into homeland security, today provided additional information regarding Scanary Ltd. (“Scanary”), an Israeli deep-tech startup’s groundbreaking AI-powered radar system that promises to redefine concealed threat detection without disrupting the flow of people. In an era of emerging security threats-from mass shootings to terrorist attacks in crowded public spaces—traditional security screening methods are increasingly inadequate. Long lines at metal detectors and X-ray machines create bottlenecks, frustrate crowds, and leave vulnerabilities in open areas where threats can enter undetected. Enter Scanary Ltd. (“Scanary”), an Israeli deep-tech startup’s...

Continue reading

Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth

Vancouver, Canada, Dec. 24, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today reflected on a year of significant momentum and progress in advancing its lead candidate, CMND-100, for the treatment of Alcohol Use Disorder (AUD). Throughout 2025, Clearmind achieved critical milestones in its FDA-approved Phase I/IIa clinical trial for CMND-100, a proprietary non-hallucinogenic MEAI-based oral compound designed to address AUD—a condition affecting millions worldwide with limited effective treatment options. Key 2025 highlights include: Clinical Trial Progress: Advanced the multinational Phase I/IIa...

Continue reading

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial results for the periods ended August 31, 2025 and November 30th, respectively. All figures are reported in Canadian dollars. The Company’s full set of Audited Financial Statements for the 2025 fiscal year, as well as its unaudited condensed interim consolidated financial statements for the first quarter of its 2026 fiscal year, and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.PharmAla.ca and its profile page on SEDAR+ at www.sedarplus.ca. “Commencing...

Continue reading

Cerence Announces Repurchase of $30 Million of 1.50% Convertible Senior Notes Due 2028

BURLINGTON, Mass., Dec. 24, 2025 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that, in light of its current cash position and outlook for future cash generation, the Company entered into privately negotiated transactions with certain holders of its 1.50% Convertible Senior Notes Due 2028 (the “Notes”), pursuant to which the Company agreed to repurchase $30 million aggregate principal amount of the Notes from such holders at a cash repurchase price equal to 92% of their principal amount, together with the accrued and unpaid interest thereon to (but not including) the settlement date. The repurchase of the Notes at a price below par represents a strategic decision by the Company to utilize its cash reserves efficiently. The transaction...

Continue reading

Copper Quest Closes Second and Final Tranche of Flow-Through Private Placement

// Not for distribution to the United States newswire services or for dissemination in the United States // VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) — Copper Quest Exploration Inc. (CSE: CQX; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that, further to its news release dated December 10, 2025, it has issued an aggregate of 579,764 flow-through shares of the Company (the “FT Shares“, and each, a “FT Share“) at a price of $0.19 per FT Share for aggregate gross proceeds of $110,155.16 in connection with the closing of the second and final tranche of its previously announced non-brokered private placement (the “Private Placement“). Each FT Share constitutes a “flow-through share” within the meaning of the Income Tax Act (Canada) (the “Tax Act“)...

Continue reading

Richtech Robotics Debuts Mobile Humanoid Robot Dex at CES 2026

Features enhanced functionality of industrial humanoid robot Dex, integrating compounding real-world data, simulation training and a robotics framework to drive productivity and efficiencies in Commercial & Industrial LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) — Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a U.S.-based provider of AI-driven robots operating in commercial and industrial environments, will demonstrate its robotics solution platform, presented by humanoid robot Dex, at CES 2026 being held from January 6 to 9, 2026, at the Las Vegas Convention Center (LVCC). Accelerated by the NVIDIA Jetson Thor, Dex is capable of operating in dynamic environments, adapting with real time reasoning, and performing complex tasks with detailed precision, all while operating for four hours on a single...

Continue reading

CHAR Tech Provides Thorold Update and Announces Engagement of European Focused Investor Relations

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) — CHAR Technologies Ltd. (“CHAR Tech” or the “Company”) (TSXV:YES), a leader in sustainable energy solutions, is pleased to provide an update on the Company’s Thorold Renewable Energy Facility in Thorold, Ontario (the “Thorold Facility”). Over the past two weeks, the Thorold Facility has taken delivery of several key equipment packages, including the kiln’s thermal management (heating) system, biochar cooling conveyors and cooling system, dust collection system, and a specialty air-lock conveyor. Installation and integration activities are now underway for this equipment. “The delivery of these systems continues to support the ongoing construction at Thorold as we move towards commercial Phase 1, biocarbon, production,” said Andrew White, CEO of CHAR Tech. In parallel with construction activities,...

Continue reading

Lead Real Estate’s ENT TERRACE GINZA PREMIUM Named “Luxury Apartments of the Year in Kantō” at Travel & Hospitality Awards 2025

International Recognition Within First Year of Operation Validates LRE’s “Stay Like Living” Concept as Affluent Travelers Prioritize Authentic, Residential-Style Experiences TOKYO, Dec. 24, 2025 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd (Nasdaq: LRE), a premier Japanese real estate developer, today announced that ENT TERRACE GINZA PREMIUM was named “Luxury Apartments of the Year in Kantō” at the Travel & Hospitality Awards 2025 on October 31, 2025. The recognition came just ten months after the property’s grand opening on December 16, 2024, underscoring the strength of LRE’s strategy to capture growing demand for premium extended-stay accommodations in Japan’s resurgent tourism market. ENT TERRACE GINZA PREMIUM is the flagship of Lead Real Estate’s premium extended-stay...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.